Steven Reed

Steve Reed is CEO of HDT Bio in Seattle, and Curevo’s Executive Advisor and Director. His academic appointments include Professor of Medicine at Cornell University Medical College in New York and a Research Professor of Pathobiology at the University of Washington. He serves on several editorial review committees, has served as a member of the Tropical Medicine Review Board of the National Institutes of Health, and has served as a member of diagnostic and vaccine steering committees of the World Health Organization. Steve’s research interests have focused on the immunology of intracellular infections, and the development of vaccines and diagnostics for both cancer and infectious diseases. In addition to HDT, he has founded the Infectious Disease Research Institute (IDRI) and co-founded two other biotech companies, Immune Design Corp and Corixa Corp.